Skip to main content
Journal of Acute Medicine logoLink to Journal of Acute Medicine
. 2024 Sep 1;14(3):130–133. doi: 10.6705/j.jacme.202409_14(3).0005

Invasive Listeriosis After Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection

Yu Ching Wang 1,2, Hsiang-Chin Hsu 1,2, Hsin-I Shih 1,2,
PMCID: PMC11366690  PMID: 39229357

Abstract

Acute deteriorated consciousness is commonly reported in elderly COVID-19 patients. Secondary bacterial infection is common in critically ill COVID-19 patients. Listeria monocytogenes is a gram-positive, facultatively intracellular rod-shaped bacterium ubiquitously distributed in the environment and is an opportunistic and foodborne pathogen. Pregnant women and their newborns, adults aged 65 years or older, and immunocompromised people are more vulnerable to Listeria -related invasive disease. A 74-year-old man with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection with initial presentations of headache and acute disorientation, which was finally diagnosed with L . monocytogenes bacteremia and meningitis. Multiplex polymerase chain reaction (Multiplex PCR) assay was used to rapidly diagnose it in the emergency department.

Keywords: Keywords: Listeria monocytogenes , Listeriosis , Multiplex PCR

Introduction

Listeria monocytogenes is a gram-positive, facultatively intracellular rod-shaped bacterium ubiquitously distributed in the environment and is an opportunistic and foodborne pathogen. Pregnant women and their newborns, adults aged 65 years or older, and immunocompromised people are more vulnerable to Listeria -related invasive disease. However, L. monocytogenes is an uncommon pathogen involved in secondary bacterial infection in patients contracting coronavirus disease 2019 (COVID-19), 1 which may lead to delayed diagnosis. Herein, we present the case of a 74-year-old man with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection with initial presentations of headache and acute disorientation, which was finally diagnosed with L. monocytogenes bacteremia and meningitis. Multiplex polymerase chain reaction (Multiplex PCR) assay was used to rapidly diagnose it. He fully recovered without neurological sequela after receiving appropriate antimicrobial treatment.

Case Report

A seventy-four-year-old male with a medical history of hypertension and dyslipidemia received four SARS-CoV-2 vaccination doses. He was diagnosed with SARS-CoV-2 infection by rapid antigen test, with symptoms of frequent cough five days before admission, and started to take the traditional Chinese medicine formula NRICM101 since then. He later developed vomiting, diarrhea (2–3 times per day), urinary incontinence, decreased appetite, chills, severe headache, and high systolic blood pressure over 200 mmHg at home. In addition, severe headache, mild fever (37.5 °C), acute disorientation with slurred speech, and bizarre behavior were noted in the emergency department. The laboratory examination is listed in Table 1 . Cerebrospinal fluid (CSF) analyses presented an opening pressure of 24 mmH 2 O, a closing pressure of 20 mmH 2 O, pleocytosis (white blood cell [WBC]: 323/μL) with a predominance of neutrophils (47%), elevated total protein (333 mg/dL), and increased lactate (10.6 mmol/L) ( Table 1 ), suggesting bacterial meningitis. FilmArray meningitis/encephalitis panel testing (BioFire Diagnostics, LLC) of CSF was positive for L. monocytogenes . Blood and CSF cultures also yielded L. monocytogenes five days later. The patient later received ampicillin with one week of gentamycin for L. monocytogenes bacteremia and meningitis; nirmatrelvir/ritonavir was also administered to treat coexisting COVID-19. His fever subsided, and consciousness recovered to the previous levels on the third day after antimicrobial therapy. He recovered without neurological sequelae.

Table 1 . Laboratory results of this case .

a BioFire Diagnostics, LLC.

Variable

Results

Normal values

Blood

WBC (/μL)

14,800

3,400–9,500

Segment (%)

89.4

40.8–76.6

Lymphocyte (%)

3.8

15.4–47.0

Monocyte (%)

6.4

4.4–11.8

Hb (g/dL)

14.9

13.3–17.2

Platelet (/μL)

152

143–349

Blood culture

Listeria monocytogenes

No growth

CSF

Pressure (cmH 2 O)

24

5–20

CSF appearance

Clear

Clear

White cell count (/μL)

323

0–5

Neutrophil (%)

47

0–6

Lymphocyte (%)

30

40–80

Monocyte (%)

19

15–45

Protein (mg/dL)

146

15–45

Glucose (mg/dL)

63

40–70

Glucose CSF: serum ratio

0.41

0.6

Lactate (mmol/L)

10.6

1.1–2.4

Gram stain

Not found

Not found

Culture

Listeria monocytogenes

No growth

FilmArray a

Listeria monocytogenes

Not detected

Discussion

Acute deteriorated consciousness is commonly reported in COVID-19 patients. SARS-CoV-2-associated or SARS-CoV-2-mediated encephalitis is the most common type observed (59.3%), followed by autoimmune encephalitis. 2 , 3

Bacterial or fungal co-infections among COVID-19 patients are not common. Previous studies suggested that about 3%–9% of COVID-19 patients have co-infections. 1 , 4 - 7 Secondary bacterial infection is a notable complication associated with worse outcomes in COVID-19 patients. 1 , 8 Listeriosis can result in invasive diseases, especially central nervous system (CNS) infections such as meningitis, meningoencephalitis, rhombencephalitis, or cerebritis. Pregnant women, newborns, adults aged 65 years or older, and immunocompromised patients are considered more vulnerable to Listeriosis. However, few studies have discussed the relationship between Listeriosis and COVID-19. 9 Our report highlighted the importance of Listeria bacteremia and meningitis in COVID-19 patients.

Innate and adaptive immunity is critical for controlling L. monocytogenes infection. 10 The innate immune mechanisms are triggered within minutes to hours after infection. Although they are not microbe specific, they are able to limit the exponential growth of L. monocytogenes and may even reduce bacterial dissemination to secondary infection sites. Weak or delayed innate immunity allows L. monocytogenes to replicate exponentially for several days and thus is a major determinant of disease severity. SARS-CoV-2 infection induces gut microbiome dysbiosis associated with bacterial translocation into the blood. 11 Furthermore, T cell functions are dysregulated and exhausted after acute SARS-CoV-2 infection and gut dysbiosis 12 , leading to imbalanced cellular immunity. 13 Therefore, L. monocytogenes , an opportunistic and foodborne pathogen, might more easily invade COVID-19 patients and end up with bacteremia and meningitis.

Timely microbiological diagnosis of CNS infections is challenging due to limited access and time to CNS samples. L. monocytogenes is not as common as Streptococcus pneumonia , Haemophilus influenzae , and Neisseria meningitidis in acute bacterial meningitis; therefore, most cases with L. monocytogenes meningitis were diagnosed by conventional microbiology cultures. Utilizing the Multiplex PCR assay is associated with a faster turnaround time of CSF testing and increased yield of viral and bacterial organisms. Although not especially technique and labor-intensive or time consuming, conventional processes of microscopy and culture for microbiological analysis of CSF have relatively poor diagnostic accuracy and reliability. In our case, the diagnosis of L. monocytogenes meningitis was five days earlier than the conventional microbiologic cultures by using multiplex PCR. Rapid and accurate diagnosis of multiplex PCR indeed shortens the diagnosis time and improves antimicrobial stewardship targeting a reduction in the duration of empiric treatment while enhancing patient outcomes. 14 , 15

In conclusion, secondary bacterial infection is common in critically ill COVID-19 patients. As SARS-CoV-2 infection can lead to an immunocompromised condition, opportunistic pathogens such as L. monocytogenes and more severe complications should be considered. High suspicion of L. monocytogenes invasive disease related to SARS-CoV-2 infection with multiplex PCR is crucial in early detecting this uncommon condition.

References

  • 1. Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis . 2020;71:2459-2468. doi: 10.1093/cid/ciaa530 [DOI] [PMC free article] [PubMed]
  • 2. Islam MA, Cavestro C, Alam SS, Kundu S, Kamal MA, Reza F. Encephalitis in patients with COVID-19: a systematic evidence-based analysis. Cells . 2022;11:2575. doi: 10.3390/cells11162575 [DOI] [PMC free article] [PubMed]
  • 3. Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol . 2021;268:3059-3071. doi: 10.1007/s00415-021-10406-y [DOI] [PMC free article] [PubMed]
  • 4. Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect . 2021;27:520-531. doi: 10.1016/j.cmi.2020.12.018 [DOI] [PMC free article] [PubMed]
  • 5. Palanisamy N, Vihari N, Meena DS, et al. Clinical profile of bloodstream infections in COVID-19 patients: a retrospective cohort study. BMC Infect Dis . 2021;21:933. doi: 10.1186/s12879-021-06647-x [DOI] [PMC free article] [PubMed]
  • 6. Garcia-Vidal C, Sanjuan G, Moreno-García E, et al.; COVID-19 Researchers Group. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect . 2021;27:83-88. doi: 10.1016/j.cmi.2020.07.041 [DOI] [PMC free article] [PubMed]
  • 7. Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect . 2020;26:1395-1399. doi: 10.1016/j.cmi.2020.06.025 [DOI] [PMC free article] [PubMed]
  • 8. Guziejko K, Czupryna P, Zielenkiewicz-Madejska EK, Moniuszko-Malinowska A. Pneumococcal meningitis and COVID-19: dangerous coexistence. A case report. BMC Infect Dis . 2022;22:182. doi: 10.1186/s12879-022-07156-1 [DOI] [PMC free article] [PubMed]
  • 9. Bokhari SFH, Sattar H, Abid S, Jaffer SR, Sajid S. Listerial meningitis and brain abscess with coexisting COVID-19 infection in a young, immunocompetent male: a case report. Cureus . 2022;14:e29455. doi: 10.7759/cureus.29455 [DOI] [PMC free article] [PubMed] [Retracted]
  • 10. D’Orazio SEF. Innate and adaptive immune responses during Listeria monocytogenes infection. Microbiol Spectr . 2019;7:10. doi: 10.1128/microbiolspec.GPP3-0065-2019 [DOI] [PMC free article] [PubMed]
  • 11. Venzon M, Bernard-Raichon L, Klein J, et al. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation. Res Sq 2021:rs. . 3.rs-726620. doi:10.21203/rs.3.rs-726620/v1 [Update in Nat Commun 2022;13:5926]. doi: 10.21203/rs.3.rs-726620/v1 [Update in Nat Commun 2022;13:5926]. [DOI] [PMC free article] [PubMed]
  • 12. Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK. COVID-19 and gut immunomodulation. World J Gastroenterol . 2021;27:7925-7942. doi: 10.3748/wjg.v27.i46.7925 [DOI] [PMC free article] [PubMed]
  • 13. Kuri-Cervantes L, Pampena MB, Meng W, et al. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci Immunol . 2020;5:eabd7114. doi: 10.1126/sciimmunol.abd7114 [DOI] [PMC free article] [PubMed]
  • 14. Cailleaux M, Pilmis B, Mizrahi A, et al. Impact of a multiplex PCR assay (FilmArray ® ) on the management of patients with suspected central nervous system infections. Eur J Clin Microbiol Infect Dis . 2020;39:293-297. doi: 10.1007/s10096-019-03724-7 [DOI] [PubMed]
  • 15. Mostyn A, Lenihan M, O’Sullivan D, et al. Assessment of the FilmArray ® multiplex PCR system and associated meningitis/encephalitis panel in the diagnostic service of a tertiary hospital. Infect Prev Pract . 2020;2:100042. doi: 10.1016/j.infpip.2020.100042 [DOI] [PMC free article] [PubMed]

Articles from Journal of Acute Medicine are provided here courtesy of Taiwan Society of Emergency Medicine

RESOURCES